Sofia Lisanti
Sofia Lisanti
Former Post-Doctoral Fellow, The Wistar Institute
Verified email at
Cited by
Cited by
Comparison of methods for quantification of global DNA methylation in human cells and tissues
S Lisanti, WAW Omar, B Tomaszewski, S De Prins, G Jacobs, G Koppen, ...
PloS one 8 (11), e79044, 2013
Mitochondrial Akt regulation of hypoxic tumor reprogramming
YC Chae, V Vaira, MC Caino, HY Tang, JH Seo, AV Kossenkov, ...
Cancer cell 30 (2), 257-272, 2016
Landscape of the mitochondrial Hsp90 metabolome in tumours
YC Chae, A Angelin, S Lisanti, AV Kossenkov, KD Speicher, H Wang, ...
Nature communications 4 (1), 2139, 2013
Control of tumor bioenergetics and survival stress signaling by mitochondrial HSP90s
YC Chae, MC Caino, S Lisanti, JC Ghosh, T Dohi, NN Danial, ...
Cancer cell 22 (3), 331-344, 2012
Adaptive mitochondrial reprogramming and resistance to PI3K therapy
JC Ghosh, MD Siegelin, V Vaira, A Faversani, M Tavecchio, YC Chae, ...
Journal of the National Cancer Institute 107 (3), dju502, 2015
Karyopherin-α2 protein interacts with Chk2 and contributes to its nuclear import
L Zannini, D Lecis, S Lisanti, R Benetti, G Buscemi, C Schneider, D Delia
Journal of Biological Chemistry 278 (43), 42346-42351, 2003
Deletion of the mitochondrial chaperone TRAP-1 uncovers global reprogramming of metabolic networks
S Lisanti, M Tavecchio, YC Chae, Q Liu, AK Brice, ML Thakur, ...
Cell Reports 8 (3), 671-677, 2014
DNA damage-induced cell cycle regulation and function of novel Chk2 phosphoresidues
G Buscemi, L Carlessi, L Zannini, S Lisanti, E Fontanella, S Canevari, ...
Molecular and cellular biology 26 (21), 7832-7845, 2006
The shelterin protein TRF2 inhibits Chk2 activity at telomeres in the absence of DNA damage
G Buscemi, L Zannini, E Fontanella, D Lecis, S Lisanti, D Delia
Current Biology 19 (10), 874-879, 2009
Cyclophilin D Extramitochondrial Signaling Controls Cell Cycle Progression and Chemokine-directed Cell Motility*[S]
M Tavecchio, S Lisanti, A Lam, JC Ghosh, NM Martin, M O'Connell, ...
Journal of Biological Chemistry 288 (8), 5553-5561, 2013
REGγ proteasome activator is involved in the maintenance of chromosomal stability
L Zannini, D Lecis, G Buscemi, L Carlessi, P Gasparini, E Fontanella, ...
Cell Cycle 7 (4), 504-512, 2008
Epigenetic mechanisms underlying arsenic-associated lung carcinogenesis
SGJ van Breda, SMH Claessen, K Lo, M van Herwijnen, KJJ Brauers, ...
Archives of toxicology 89, 1959-1969, 2015
Deletion of cyclophilin D impairs β-oxidation and promotes glucose metabolism
M Tavecchio, S Lisanti, MJ Bennett, LR Languino, DC Altieri
Scientific reports 5 (1), 15981, 2015
Inhibition of age-related therapy resistance in melanoma by rosiglitazone-mediated induction of Klotho
R Behera, A Kaur, MR Webster, S Kim, A Ndoye, CH Kugel III, GM Alicea, ...
Clinical Cancer Research 23 (12), 3181-3190, 2017
Transgenic expression of the mitochondrial chaperone TNFR-associated protein 1 (TRAP1) accelerates prostate cancer development
S Lisanti, DS Garlick, KG Bryant, M Tavecchio, GB Mills, Y Lu, ...
Journal of Biological Chemistry 291 (48), 25247-25254, 2016
REGγ/PA28γ proteasome activator interacts with PML and Chk2 and affects PML nuclear bodies number
L Zannini, G Buscemi, E Fontanella, S Lisanti, D Delia
Cell Cycle 8 (15), 2399-2407, 2009
Standardization and quality controls for the methylated DNA immunoprecipitation technique
S Lisanti, T von Zglinicki, JC Mathers
Epigenetics 7 (6), 615-625, 2012
Chk2 phosphorylation of survivin-ΔEx3 contributes to a DNA damage–sensing checkpoint in cancer
A Lopergolo, M Tavecchio, S Lisanti, JC Ghosh, T Dohi, A Faversani, ...
Cancer research 72 (13), 3251-3259, 2012
Changes in DNA methylation patterns in mammals with senescence, ageing and energy restriction
S Lisanti
Newcastle University, 2013
Epigenomics: Understanding how nutrition modulates the ageing process
S Lisanti, JC Mathers
Journal of Nutrigenetics and Nutrigenomics, 2010
The system can't perform the operation now. Try again later.
Articles 1–20